Ventricular functions in children with human immunodeficiency virus infection after ACE-inhibitors.
dc.contributor.author | Anuroj, K | en_US |
dc.contributor.author | Pathmanand, C | en_US |
dc.contributor.author | Sueblinvong, V | en_US |
dc.contributor.author | Thisyakorn, C | en_US |
dc.contributor.author | Chotivitayatarakorn, P | en_US |
dc.date.accessioned | 2009-05-27T16:53:53Z | |
dc.date.available | 2009-05-27T16:53:53Z | |
dc.date.issued | 1997-06-01 | en_US |
dc.description | The Southeast Asian Journal of Tropical Medicine and Public Health. | en_US |
dc.description.abstract | Nine pediatric symptomatic patients infected with human immunodeficiency virus with elevated pulmonary arterial pressure (MPA pressure) and ejection fraction (EF); and with fractional shortening, (FS) mean velocity of circumferential fiber shortening (MVCfc) and left ventricular peak systolic wall stress (PS) were prospectively evaluated using 2-dimensional and M-mode serial echocardiography and Doppler cardiography after administration of an ACE inhibitor (Inhibace 0.025 mg/kg/D orally) for 12 weeks. The MPA pressure was not decreased, however the MVCfc and PS improved significantly (p < 0.05). Further, long term evaluation is required to determine its effect in preventing dilated cardiomyopathy and elevated mean pulmonary pressure. | en_US |
dc.description.affiliation | Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand. | en_US |
dc.identifier.citation | Anuroj K, Pathmanand C, Sueblinvong V, Thisyakorn C, Chotivitayatarakorn P. Ventricular functions in children with human immunodeficiency virus infection after ACE-inhibitors. The Southeast Asian Journal of Tropical Medicine and Public Health. 1997 Jun; 28(2): 375-9 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/36258 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.tm.mahidol.ac.th/seameo/publication.htm | en_US |
dc.subject.mesh | Angiotensin-Converting Enzyme Inhibitors --therapeutic use | en_US |
dc.subject.mesh | Cardiomyopathy, Dilated --prevention & control | en_US |
dc.subject.mesh | Child, Preschool | en_US |
dc.subject.mesh | Cilazapril --therapeutic use | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | HIV Infections --complications | en_US |
dc.subject.mesh | Hemodynamics | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hypertension, Pulmonary --drug therapy | en_US |
dc.subject.mesh | Infant | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Prospective Studies | en_US |
dc.subject.mesh | Statistics, Nonparametric | en_US |
dc.subject.mesh | Ventricular Dysfunction --drug therapy | en_US |
dc.title | Ventricular functions in children with human immunodeficiency virus infection after ACE-inhibitors. | en_US |
dc.type | Clinical Trial | en_US |
dc.type | Journal Article | en_US |
dc.type | Research Support, Non-U.S. Gov't | en_US |
Files
License bundle
1 - 1 of 1